1-3 of 3
Andelko Hrzenjak
Close
Sort by
Journal Articles

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

Philipp B. Staber, Paul Vesely, Naznin Haq, Rene G. Ott, Kotaro Funato, Isabella Bambach, Claudia Fuchs, Silvia Schauer, Werner Linkesch, Andelko Hrzenjak, Wilhelm G. Dirks, Veronika Sexl, Helmut Bergler, Marshall E. Kadin, David W. Sternberg, Lukas Kenner, Gerald Hoefler
Journal: Blood
Blood (2007) 110 (9): 3374–3383.
https://doi.org/10.1182/blood-2007-02-071258
Published: 2007
Includes: Supplemental data
Journal Articles

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Paul Vesely, MS, Philipp B. Staber, MD, Rene Ott, PhD, Montserrat Pinent, PhD, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD
Journal: Blood
Blood (2006) 108 (11): 1448.
https://doi.org/10.1182/blood.V108.11.1448.1448
Published: 2006
Journal Articles

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

Philipp B. Staber, MD, Paul Vesely, MS, Rene Ott, PhD, Naznin Haq, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Lukas Kenner, MD, Wilhelm Dirks, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD
Journal: Blood
Blood (2006) 108 (11): 1428.
https://doi.org/10.1182/blood.V108.11.1428.1428
Published: 2006